State Of Wyoming Silverback Therapeutics, Inc. Transaction History

State Of Wyoming

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	N/A	-5 Reduced 4.1%	117 $0
Q4 2022 Feb 14, 2023	BUY	$0.0 - $6.07 $0 - $540	89 Added 269.7%	122 $0
Q3 2022 Nov 14, 2022	BUY	$3.91 - $5.52 $129 - $182	33 New	33 $0
Q4 2021 Feb 11, 2022	SELL	$6.03 - $11.67 $84 - $163	-14 Closed	0 $0
Q3 2021 Feb 11, 2022	SELL	$9.98 - $35.22 $59 - $211	-6 Reduced 30.0%	14 $0

Q2 2021 Feb 11, 2022	BUY	$24.71 - $44.28 $271 - $487	11 Added 122.22%	20 $1,000
Q1 2021 Feb 08, 2022	BUY	$37.62 - $60.41 $338 - $543	9 New	9 $0

117

47.9M

442K

42K

Ticker SBTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,473,800
Description
Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.